Male Breast Reduction (Gynecomastia)

Liposuction of the breast area in men is one of the most common areas to be treated with this procedure. The normal male breast contains both fat and breast tissues. True breast tissue in men is typically a small lump under the nipple that is more firm than the surrounding fatty tissue. It is easy to remove fatty breast tissue by liposuction, but much more difficult to liposuction breast tissue. It is challenging to predict the final result since it is sometimes difficult to assess the relative amount of fat and true  breast tissue.

30670tn

Pseudo-gynecomastia
Enlargement of male breast(s) caused by an excessive amount of fat tissue, but a normal amount of  breast tissue. Most male breasts that appear unusually large are the result of excess fat. With age many men develop fatty breast. Excessively fatty breasts are not uncommon in younger men who are relatively obese.

True Gynecomastia
This is defined as enlargement of male breast(s) caused by excessive  breast tissue. A true gynecomastia in men is uncommon. True gynecomastia can be caused alcoholism, low testosterone, and some medications. Bilateral gynecomastia can also be associated with human immunodeficiency virus (HIV) infection, renal failure treated with hemodialysis, certain cancers such as testicular cancer, and adrenal corticosteroid secreting tumors. If a male has a single enlarged breast then one must consider the possibility of a tumor. Any significant asymmetry of the male breasts, especially if there is a history of recent onset of asymmetric growth, may require mammogram.

Drugs Drugs that can cause gynecomastia include amiloride (Moduretic), amiodarone (Cordarone), amphetamines, anabolic steroids, antiandrogens (cyproterone), anticancer (cytotoxic) drugs, androgens, busulfan (Myleran), captopril (Capoten), cimetidine (Tagamet), clomiphene (Clomid), diazepam (Valium), diethylpropion (Tenuate), digitalis, domperidone, estrogens, isoniazid, ketoconazole (Nizoral), marijuana, methyldopa, metoclopramide, nifedipine (Procardia), nitrosourea, penicillamine, phenothiazines, phenytoin (Dilantin), reserpine, spironolactone (Aldactone), tricyclic antidepressants, vincristine.

Normal Temporary Gynecomastia after puberty
During puberty 60% of normal boys experience temporary breast enlargement that usually disapear within a few months.

Liposuction For Enlarged Male Breasts
Liposuction is most effective for pseudo-gynecomastia. For true gynecomastia, the breast tissue is dense and fibrous and therefore difficult to penetrate and remove with a liposuction cannula. Among normal healthy men there is a wide range of the relative amount of fatty tissue and glandular tissue found in the breasts. Most healthy men have a small amount of breast tissue and a larger amount of fatty tissue in their breasts. Microcannulas are effective in removing both breast tissue and fatty tissue from the normal male breast. Exceptionally dense glandular breast tissue may require surgical removal.

Male Liposuction by Local Anesthesia

Tumescent liposuction of the male breast can be done totally by local anesthesia. After gently injecting local anesthesia into the breasts liposuction would be done.

After liposuction
After liposuction is completed there would be drainage of blood-tinged fluid for a day or two. This drainage is absorbed by absorbable pads held in place by an spandex Garment. Adequate compression during the first 18 to 24 hours after surgery is necessary to prevent bleeding and excessive bruising.

Realistic Expectations
While it is not realistic to expect perfect results, most patients should see a significant improvement. It is a good idea for patients to assume that they will only achieve a 50% improvement. In fact, most men will achieve more than a 50% improvement. However, if the patient would not be satisfied with a 50% improvement then perhaps that patient’s expectations are too high and a little unrealistic.

For further information about gynecomastia  and liposuction and to schedule a consultation with Dr. Goravanchi, call our offices at (+98) 912 038 6704.